Schott launches InJentle syringe to improve drug stability

By Nick Taylor

- Last updated on GMT

Related tags: Pharmaceutical drug, Pharmacology

Schott AG has launched its InJentle syringe to improve the stability of highly sensitive drugs, which is a “major topic” for the company’s clients, according to a company director.

Speaking to in-PharmaTechnologist at Pharmapack 2010, Gregor Dudek, director, product management pharmaceutical packaging at Schott, explained that the syringe is designed to prevent the drug coming into contact with potential contaminants.

The syringe also has a tamper-evident closure and can be modified to include additional anti-counterfeiting features, such as radiofrequency identification (RFID) tags.

Additionally, sharper ‘virgin’ needles are used to make the injection less painful for patients. Particularly thin, siliconised needles can also be used to improve patient application.

Related topics: Drug Delivery, Delivery technologies

Related news

Show more

Related products

show more

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Flow Cytometry Services

Flow Cytometry Services

Q² Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

Local lab Data Management

Local lab Data Management

Q² Solutions | 01-May-2020 | Data Sheet

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...